SCHEMBL5569

SCHEMBL5569

CC(C)Oc1ccc(N2CC[C@]3(CC[C@@](O)(C(C)C)CC3)C2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 8/20 0.41
ALDH1A1 P00352 7/20 0.41
KMT2A Q03164 5/20 0.41
HSD17B10 Q99714 5/20 0.41
ALOX15 P16050 3/20 0.41
MAPT P10636 2/20 0.41
SMN1; SMN2 Q16637 4/20 0.40
KDM4E B2RXH2 1/20 0.40
FFAR4 Q5NUL3 3/20 0.39
CYP3A4 P08684 10/20 0.37
CYP2C9 P11712 7/20 0.37
CYP2C19 P33261 6/20 0.37
MEN1 O00255 4/20 0.37
MAPK1 P28482 3/20 0.37
CYP1A2 P05177 6/20 0.36
HIF1A Q16665 4/20 0.36
TSHR P16473 4/20 0.36
HPGD P15428 2/20 0.36
LIPE Q05469 3/20 0.36
CYP2D6 P10635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5301 0.84 EPHX2 (0.42) FFAR4LIPE
SCHEMBL5546 0.83 LIPE (0.44) USP2ALDH1A1KMT2AHSD17B10ALOX15
SCHEMBL6125 0.82 FFAR4 (0.41) USP2ALDH1A1KMT2AHSD17B10ALOX15
SCHEMBL5548 0.80 CYP3A4 (0.36) USP2ALDH1A1KMT2AHSD17B10ALOX15
SCHEMBL4617 0.79 CYP3A4 (0.42) USP2KMT2AHSD17B10CYP3A4CYP2C9
SCHEMBL5081 0.79 SIGMAR1 (0.41) USP2ALDH1A1KMT2AHSD17B10ALOX15
SCHEMBL11842 0.76 LIPE (0.35) USP2ALDH1A1KMT2AHSD17B10ALOX15
SCHEMBL5214 0.76 S1PR1 (0.40) USP2ALDH1A1KMT2AHSD17B10ALOX15
SCHEMBL10123 0.72 LIPE (0.65) LIPE
SCHEMBL10124 0.72 LIPE (0.65) LIPE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP claimed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO claimed